Bacterial toxins as tools for mucosal vaccination
Related Experiment Video
Updated: Oct 2, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria
Published on: December 8, 2023
Randall J Mrsny1, Ann L Daugherty, Marian L McKee
1Cardiff University, Center for Drug Delivery/Biology, Welsh School of Pharmacy, Redwood Building, King Edward VII Avenue, Cardiff, UK CF10 3XF. mrsnyr@cf.ac.uk
Abstract:
Several studies have demonstrated that the biological properties of secreted bacterial toxins could be harnessed for the induction of mucosal and systemic immunity following application at epithelial surfaces. Although the properties and potential application of several of these toxins will be discussed in this review, special focus will be placed on Pseudomonas aeruginosa exotoxin A (PE). A non-toxic form of PE (ntPE) into which antigenic epitopes can be integrated appears to be a particularly promising vaccination tool, which is able to cross the polarized epithelia of the gastrointestinal, respiratory and reproductive tracts and selectively target macrophages and dendritic cells.
More Related Videos
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
06:32Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
Published on: September 19, 2016
Related Concept Videos
Bacterial Toxins
Microorganisms in Medicine and Therapeutics
Vaccines
Vaccine Production
Vaccinations
Determinants of Bacterial Pathogenicity and Virulence